BrightSpring Health Services, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BrightSpring Health Services, Inc. on October 11, 2024. The filing reports the departure of a senior officer and the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation details related to the departure of Steven S. Reed.
Material Changes
Steven S. Reed, Chief Legal Officer and Corporate Secretary, retired from his position effective October 11, 2024, after over twenty years of service. He will transition to a role as senior legal counsel through March 31, 2025. The Company has initiated a search for a successor.
Compensatory Arrangements and Agreements
Two agreements govern Mr. Reed's transition:
- Amended and Restated Employment Agreement: Effective October 1, 2024, Mr. Reed's compensation is limited to a monthly base salary of $20,000. The agreement includes confidentiality, non-competition, and non-solicitation restrictions for 12 months post-employment. It provides for accelerated vesting of certain unvested stock options and restricted stock units if employment is terminated without cause or if he resigns for good reason.
- Special Retention Agreement: Subject to execution and non-revocation, this agreement provides:
- A lump sum payment of $181,018 within 90 days of the release effective date.
- A lump sum payment of $271,412 in calendar year 2025 as consideration for forfeiting 2024 short-term incentive compensation (calculated at 100% target).
- Up to six months of employer-paid COBRA premiums.
Additionally, if Mr. Reed remains employed until March 31, 2025 (or earlier termination without cause/resignation for good reason) and executes a release, he is entitled to:
- A payment of $724,032 in equal installments over 24 months following the Termination Date.
- Up to 12 months of employer-paid COBRA premiums following the Termination Date.
- Extension of vested stock option exercise periods to December 31, 2027.
- Extension of unvested performance-based stock option vesting periods to March 31, 2026.
Investor Verification Checklist
- Verify the total potential cash compensation payable to Mr. Reed under the Retention Agreement ($1,176,462 in aggregate cash payments if all conditions are met).
- Confirm the status of the search for a new Chief Legal Officer and Corporate Secretary.
- Review the full text of Exhibits 10.1 and 10.2 for specific definitions of "Cause" and "Good Reason" which trigger accelerated vesting and severance payments.
- Monitor future filings for the appointment of Mr. Reed's successor.